Q34. CCND1::IGH rearrangements can be seen in all of the following, except: A. Plasma cell myeloma B. CLL/SLL C. Mantle cell lymphoma D. Non-IgM MGUS

Shape the future of @CGC_Genomics! 🧬 We’re seeking nominations for: 🔹 Board Directors (Governance/Strategic) 🔹 Junior Director (Trainee role) Ready to lead the cancer genomics community? Submit nominations here: buff.ly/eDSn38H 🗓️ Due: April 9, 11:59 PM PDT

🎥 New on YouTube from #CGCAnnual2025: Dr. Mary Clay Bailey on FGFR alterations in pediatric CNS tumors—showing structural variants (fusions, FGFR1 TKD duplications) are more common than SNVs and clinically important. ▶️ buff.ly/6ytiCVH

Meet this month’s #CGCVolunteerSpotlight: Xinxiu (Cindy) Xu! 🧬 From the Early Career Initiative to the CCGA, Cindy’s expertise in clinical cytogenetics is making a huge impact. Her advice to fellow trainees: Stay curious & be proactive! 💡 Read more about Cindy’s journey: Link the comments 👇

The #CGC2026 Round Table Sessions are back this August in Houston! Join an intimate group to discuss the "how-to" of clinical genomics, from AI integration to T-Cell receptor assessment. 🔗 Link to register in the comments. Which session are you joining? Let us know below! 👇

Join the CGC for the second webinar in the Cytogenetic Automation Series, featuring a roundtable discussion on the strengths and hurdles of adopting automated karyotyping and FISH analyses. Learn how to decrease reporting time and optimize your clinical workflow. 🔗 Register link in the comments 👇

Q34. CCND1::IGH rearrangements can be seen in all of the following, except: A. Plasma cell myeloma B. CLL/SLL C. Mantle cell lymphoma D. Non-IgM MGUS Type your answer in the chat below and come back next week for the answer and explanation!

Registration is OPEN for the 17th Annual CGC Meeting! 🧬 📅 Aug 1-5, 2026 📍 Houston, TX + Hybrid Options 💡 Latest in Cancer Genomics & Precision Medicine ⏳ Early Bird Deadline: May 21 Don’t miss the premier event for the clinical genomics community!

Our monthly Committee Spotlight is back! This month, we are highlighting the incredible work being done by the CGC Genomic Resources Development Committee. 🧬 Click here to learn more about CGC Committees: buff.ly/vrw6doR

🚨 ONE DAY LEFT! Tomorrow is the final day to submit your abstract for #CGC2026! If you have a draft saved in the portal, now is the time to hit submit. ⏰ Deadline: Tuesday, March 3 @ 11:59 PM PST 🔗 buff.ly/x1PGNmB #CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting

Final Days: Abstract Submissions for CGC 2026 Close Tuesday! Planning to submit your research for the CGC 2026 Annual Meeting? This is your final weekend to polish those drafts. Submissions close this Tuesday, March 3. 🔗 Submit your abstract before the Tuesday deadline: buff.ly/x1PGNmB

Shape the Future of Genomics 🧬 CGC is calling for members to join two new Working Groups: • Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Genomics • Predisposition to Hematological Malignancies 📅 Apply by March 19, 2026 🔗 Link to apply in the comments👇

What resonated with you today? 🎤 Thank you to everyone who joined the CGC Early Career Committee’s Fireside Chat! We covered everything from navigating career transitions to seizing new opportunities in genomics. Share your thoughts in the comments! 💬 #CancerGenomics #CareerGrowth #CGC

Don’t miss the #CGCAnnual2025 session: Cancer Genome Bioinformatics in a Clinical Setting! Dr. Mark Cowley shares insights from the ZERO Childhood Cancer Program. Dr. Sheryl Elkin discusses scalable approaches for delivering clinical information. Watch: buff.ly/cv4ZGDr #Genomics #CancerResearch

Q33. A young man underwent hereditary cancer testing because of family history. He was found to have a pathogenic variant in promoter region of APC. Which of the following risk is increased in this patient? A. Attenuated colon polyps B. Colon cancer C. Gastric cancer D. Osteomas

🧬 Time is running out to share your work at CGC 2026! The Call for Abstracts is entering its final days, and we would truly love to see your research featured. Submit soon to secure your spot: 🔗 buff.ly/YJ3KOqn

We’re pleased to share Dr. Sharon Savage’s keynote at #CGCAnnual2025. She discusses the link between telomere biology and cancer, including research on telomere length, cancer risk, and genetic factors. Watch: buff.ly/5v34gSC #TelomereBiology #CancerResearch #Genomics #CGCAnnual2025 #Keynote

Q33. A young man underwent hereditary cancer testing because of family history. He was found to have a pathogenic variant in promoter region of APC. Which of the following risk is increased in this patient? A. Attenuated colon polyps B. Colon cancer C. Gastric cancer D. Osteomas

Are you passionate about genomics and driven to make an impact in the cancer genomics community? The CCGA is actively recruiting new volunteers to serve as authors and mentors. Learn more here: buff.ly/Gyobssn

🌟 Early Career Pros: Level Up! 🌟 Join the CGC Early Career Committee for "Mentors, Moments, & Mistakes" on Feb 25, 2026! Hear leaders in genetics/genomics share personal stories, pivotal moments, & lessons learned. 🗓️ 9 AM PT / 12 PM ET 🔗 buff.ly/HGgB4U1 #CancerGenomics #EarlyCareer #Mentorship

Q32. In AML with t(8;21), KIT mutations are associated with A. Good prognosis B. Adverse prognosis C. Standard prognosis D. Controversial prognosis

Check out Dr. Hagop Kantarjian’s keynote presentation at #CGCAnnual2025! He covers molecular-genomic findings in leukemias and their diagnostic, prognostic, and therapeutic implications. Watch here: buff.ly/s0etRp7 #Leukemia #Genomics #Diagnostics #Prognosis #Therapy

🌟 Early Career Pros: Level Up! 🌟 Join the CGC Early Career Committee for "Mentors, Moments, & Mistakes" on Feb 25, 2026! Hear leaders in genetics/genomics share personal stories, pivotal moments, & lessons learned. 🗓️ 9 AM PT / 12 PM ET 🔗 buff.ly/HGgB4U1 #CancerGenomics #EarlyCareer #Mentorship

Help us celebrate Candace Myers, PhD, FACMG , our February #CGCspotlight! ✨ We are grateful for Candace's commitment to the CGC and her contributions to the growth of the field of clinical cancer genomics. Read her full spotlight here: buff.ly/QmHCNGr 🧬 #CGC #EarlyCareer #MemberSpotlight

🧬 Call for Abstracts: Share Your Research at CGC 2026 The #CGC2026 is now accepting abstract submissions. Showcase your: ✅ Original Research ✅ Clinical Insights ✅ Innovative Approaches Submit your work and help shape the future of the field! 🧬👇 buff.ly/1KMMGx0 #CGCAnnual2026 #genomics #cancer

CGC & VICC: Stronger Together 🤝 Big news! The Variant Interpretation for Cancer Consortium (VICC) has officially integrated into the Cancer Genomics Consortium (CGC). We are excited for this new chapter of collaboration and innovation! 👉 Details here: buff.ly/pIY5bd0

Q32. In AML with t(8;21), KIT mutations are associated with A. Good prognosis B. Adverse prognosis C. Standard prognosis D. Controversial prognosis Type your answer in the chat below and come back next week for the answer and explanation!

🧬 Join our Monthly Collaborative Genomics Case Conference! We’re back on Tuesday, Feb 10th for another deep dive into the latest in genomics. This month features two compelling case presentations you won't want to miss. 🔗 Learn more here: buff.ly/FdQRA7A #genomics #cancer #research #genetics

🔬 Two must-see #CGCAnnual2025 talks now online! Dr. Lisa Lansdon: Long-read sequencing to detect structural variants in pediatric leukemia. Dr. Fritz Sedlazeck: TumorLens finds somatic variants & methylation via long-read sequencing. Watch: buff.ly/KnxoX4Q

On World Cancer Day, CGC supports this year's theme, “United by Unique”. Every cancer journey is unique and deserves a personalized approach. Through accurate genomic diagnosis and global collaboration, we advance precision oncology, and progress happens when we move forward together.

Take a look at our latest Committee Spotlight! 🧬 The Community Access and Representation (CAR) Committee is hitting major milestones, including their first-ever abstract acceptance for the CGC Annual Meeting 2026. Learn more about the committee here: buff.ly/vqOW51m #CGCVolunteers #genomics #cancer

The Call for Abstracts is officially open! Whether it’s original research, clinical insights, or an innovative breakthrough, we want to see the work you’re doing to shape the future of cancer genomics. 🔗 Submit your abstract here: buff.ly/YJ3KOqn

🌟 Early Career Pros: Level Up! 🌟 Join the CGC Early Career Committee for "Mentors, Moments, & Mistakes" on Feb 25, 2026! Hear leaders in genetics/genomics share personal stories, pivotal moments, & lessons learned. 🗓️ 9 AM PT / 12 PM ET 🔗 buff.ly/HGgB4U1 #CancerGenomics #EarlyCareer #Mentorship

🧬 Call for Abstracts: Share Your Research at CGC 2026 The #CGC2026 is now accepting abstract submissions. Showcase your: ✅ Original Research ✅ Clinical Insights ✅ Innovative Approaches Submit your work and help shape the future of the field! 🧬👇 buff.ly/1KMMGx0 #CGCAnnual2026 #genomics #cancer

Curious about boosting fusion detection in the TSO500 panel with DNA-based SV analysis? Dr. Qiliang (Andy) Ding presents this Trainee Award–winning work: buff.ly/bykpMf4 #CGCAnnual2025

Q31. Mr. Bean has recently been diagnosed of acute myeloid leukemia at 75 years old. His two brothers also had Hodgkin lymphoma and multiple myeloma. Which of the following genes might explain his personal and family history? A. FANCA B. TP53 C. MITF D. DDX41

Registration Reminder! 🧬 Join the CGC on January 27th for an essential webinar: "Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma." 🗓 Date: Tuesday, Jan 27, 2026 🕐 Time: 1:00 PM – 2:00 PM ET 🔗 Register Here: buff.ly/vlo99BZ

🧬 Call for Abstracts: Share Your Research at CGC 2026 The #CGC2026 is now accepting abstract submissions. Showcase your: ✅ Original Research ✅ Clinical Insights ✅ Innovative Approaches Submit your work and help shape the future of the field! 🧬👇 buff.ly/1KMMGx0 #CGCAnnual2026 #genomics #cancer

Join a global community shaping the future of clinical cancer genomics. Become a CGC member today and let these connections and resources position you to stay at the forefront of our rapidly evolving field. Learn more here: buff.ly/XmRisWp #CGCVolunteers #genomics #cancer #research #genetics

What does 9p21 loss reveal across cancers? Watch Dr. Holly Hill’s award-winning analysis and its clinical implications buff.ly/FTDXvGB #CGCAnnual2025

Q31. Mr. Bean has recently been diagnosed of acute myeloid leukemia at 75 years old. His two brothers also had Hodgkin lymphoma and multiple myeloma. Which of the following genes might explain his personal and family history? A. FANCA B. TP53 C. MITF D. DDX41

🌟 Early Career Pros: Level Up! 🌟 Join the CGC Early Career Committee for "Mentors, Moments, & Mistakes" on Feb 25, 2026! Hear leaders in genetics/genomics share personal stories, pivotal moments, & lessons learned. 🗓️ 9 AM PT / 12 PM ET 🔗 buff.ly/HGgB4U1 #CancerGenomics #EarlyCareer #Mentorship

Ready to master Flow Cytometry? 🧬 Join the CGC on Jan 20th at 11 AM EST for an expert-led session on principles, case studies, and genetic correlates. ✅ Bonus: Active CGC members can earn PACE credit for attending! Register now: buff.ly/Ii9V8io

How are federal regulations shaping molecular testing and gene patenting? Hear insights from invited speaker Dr. Donald Karcher at #CGCAnnual2025. 👉 Watch here: buff.ly/Dge5n9z

Congratulations to Nancy Arthur, our January #CGCVolunteerSpotlight! 👏 As a CGC trainee volunteer and Communications Committee member, Nancy plays a vital role in our community. Learn more about her here: buff.ly/kXb5OF2 #CGCVolunteers #genomics #cancer #research #genetics #clinicaltesting

Registration is OPEN! 🧬 Join the CGC on January 27th for an essential webinar: "Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma." 🗓 Date: Tuesday, Jan 27, 2026 🕐 Time: 1:00 PM – 2:00 PM ET 🔗 Register Here: buff.ly/11Rmjqy

Join a global community shaping the future of clinical cancer genomics. Become a CGC member today and let these connections and resources position you to stay at the forefront of our rapidly evolving field. Learn more here: buff.ly/XmRisWp #CGCVolunteers #genomics #cancer #research #genetics

Q30. What genetic alteration is standard risk in multiple myeloma? A. Deletion 13 by karyotype B. t(11;14) C. Deletion 17p D. t(4;14) Test your knowledge by reviewing past quiz questions here: buff.ly/IhTopbU

📅 Upcoming Webinar: Collaborative Genomics Case Conference Join the University of Wisconsin-Madison ICEP and the CGC on Tuesday, January 13, for our monthly case conference. 🔗 Learn more: buff.ly/K2JR3eU #CGCVolunteers #genomics #cancer #research #genetics #clinicaltesting #bioinformatics

Two decades of precision oncology for childhood cancer—summarized in one powerful keynote. Watch Dr. Will Parsons discuss the clinical impact of genomics. buff.ly/EMIZvvO #CGCAnnual2025